Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Non-Current Deferred Tax Liability (2024 - 2025)

Updated

Seaport Therapeutics (SPTX) reported Non-Current Deferred Tax Liability of -$1.29 million for Q4 2025, compared with -$1.34 million a year earlier.

Analysis

Seaport Therapeutics (SPTX) Non-Current Deferred Tax Liability (2024 - 2025) Analysis & Trends

  • By year, Non-Current Deferred Tax Liability came in at -$1.34 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.29 Mn
Dec 31, 2024 -1.34 Mn
API Access

Seaport Therapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=SPTX&period=max&api_key=YOUR_API_KEY